Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 54

1.

Phosphate binder pill burden, adherence, and serum phosphorus control among hemodialysis patients converting to sucroferric oxyhydroxide.

Gray K, Ficociello LH, Hunt AE, Mullon C, Brunelli SM.

Int J Nephrol Renovasc Dis. 2019 Jan 22;12:1-8. doi: 10.2147/IJNRD.S182747. eCollection 2019.

2.

One-Year Historical Cohort Study of the Phosphate Binder Sucroferric Oxyhydroxide in Patients on Maintenance Hemodialysis.

Kendrick J, Parameswaran V, Ficociello LH, Ofsthun NJ, Davis S, Mullon C, Kossmann RJ, Kalantar-Zadeh K.

J Ren Nutr. 2019 Jan 21. pii: S1051-2276(18)30254-1. doi: 10.1053/j.jrn.2018.11.002. [Epub ahead of print]

3.

Eco-Evolutionary Dynamics in Metacommunities: Ecological Inheritance, Helping within Species, and Harming between Species.

Mullon C, Lehmann L.

Am Nat. 2018 Dec;192(6):664-686. doi: 10.1086/700094. Epub 2018 Oct 18.

PMID:
30444662
4.

Effects of dialysate to serum sodium (Na+) alignment in chronic hemodialysis (HD) patients: retrospective cohort study from a quality improvement project.

Raimann JG, Ficociello LH, Usvyat LA, Zhang H, Pacelli L, Moore S, Sheppard P, Xiao Q, Wang Y, Mullon C, Balter P, Sullivan T, Kotanko P.

BMC Nephrol. 2018 Apr 2;19(1):75. doi: 10.1186/s12882-018-0870-0.

5.

Real-World Scenario Improvements in Serum Phosphorus Levels and Pill Burden in Peritoneal Dialysis Patients Treated with Sucroferric Oxyhydroxide.

Kalantar-Zadeh K, Parameswaran V, Ficociello LH, Anderson L, Ofsthun NJ, Kwoh C, Mullon C, Kossmann RJ, Coyne DW.

Am J Nephrol. 2018;47(3):153-161. doi: 10.1159/000487856. Epub 2018 Mar 7.

6.

The influence of the few: a stable 'oligarchy' controls information flow in house-hunting ants.

Richardson TO, Mullon C, Marshall JAR, Franks NR, Schlegel T.

Proc Biol Sci. 2018 Feb 14;285(1872). pii: 20172726. doi: 10.1098/rspb.2017.2726.

7.

Publisher Correction: Social polymorphism is favoured by the co-evolution of dispersal with social behaviour.

Mullon C, Keller L, Lehmann L.

Nat Ecol Evol. 2018 Jan;2(1):197. doi: 10.1038/s41559-017-0439-5.

PMID:
29230029
8.

Social polymorphism is favoured by the co-evolution of dispersal with social behaviour.

Mullon C, Keller L, Lehmann L.

Nat Ecol Evol. 2018 Jan;2(1):132-140. doi: 10.1038/s41559-017-0397-y. Epub 2017 Dec 4. Erratum in: Nat Ecol Evol. 2017 Dec 11;:.

PMID:
29203923
9.

Invasion fitness for gene-culture co-evolution in family-structured populations and an application to cumulative culture under vertical transmission.

Mullon C, Lehmann L.

Theor Popul Biol. 2017 Aug;116:33-46. doi: 10.1016/j.tpb.2017.06.003. Epub 2017 Jul 12.

PMID:
28711317
10.

Real-world effectiveness of sucroferric oxyhydroxide in patients on chronic hemodialysis: A retrospective analysis of pharmacy data
.

Coyne DW, Ficociello LH, Parameswaran V, Anderson L, Vemula S, Ofsthun NJ, Mullon C, Maddux FW, Kossmann RJ, Sprague SM.

Clin Nephrol. 2017 Aug;88(8):59-67. doi: 10.5414/CN109021.

11.

Evolutionary Stability of Jointly Evolving Traits in Subdivided Populations.

Mullon C, Keller L, Lehmann L.

Am Nat. 2016 Aug;188(2):175-95. doi: 10.1086/686900. Epub 2016 Jun 2.

PMID:
27420783
12.

Invasion fitness, inclusive fitness, and reproductive numbers in heterogeneous populations.

Lehmann L, Mullon C, Akçay E, Van Cleve J.

Evolution. 2016 Aug;70(8):1689-702. doi: 10.1111/evo.12980. Epub 2016 Jun 24.

PMID:
27282317
13.

A Comparison of Clinical Parameters and Outcomes over 1 Year in Home Hemodialysis Patients Using 2008K@home or NxStage System One.

Brunelli SM, Wilson SM, Ficociello LH, Mullon C, Diaz-Buxo JA.

ASAIO J. 2016 Mar-Apr;62(2):182-9. doi: 10.1097/MAT.0000000000000315.

PMID:
26692402
14.

Evolution of dosage compensation under sexual selection differs between X and Z chromosomes.

Mullon C, Wright AE, Reuter M, Pomiankowski A, Mank JE.

Nat Commun. 2015 Jul 27;6:7720. doi: 10.1038/ncomms8720.

15.

A year-long quality improvement project on fluid management using blood volume monitoring during hemodialysis.

Balter P, Ficociello LH, Taylor PB, Usvyat L, Sawin DA, Mullon C, Diaz-Buxo J, Zabetakis P.

Curr Med Res Opin. 2015;31(7):1323-31. doi: 10.1185/03007995.2015.1047746. Epub 2015 Jun 3.

PMID:
25942380
16.

The robustness of the weak selection approximation for the evolution of altruism against strong selection.

Mullon C, Lehmann L.

J Evol Biol. 2014 Oct;27(10):2272-82. doi: 10.1111/jeb.12462. Epub 2014 Aug 21.

17.

Effects of Crit-Line® monitor use on patient outcomes and epoetin alfa dosing following onset of hemodialysis: a propensity score-matched study.

Sibbel SP, Ficociello LH, Black M, Thakuria M, Mullon C, Diaz-Buxo J, Alfieri TJ.

Blood Purif. 2014;37(3):249-57. doi: 10.1159/000362107. Epub 2014 Jun 26.

PMID:
24970017
18.

The evolution and consequences of sex-specific reproductive variance.

Mullon C, Reuter M, Lehmann L.

Genetics. 2014 Jan;196(1):235-52. doi: 10.1534/genetics.113.156067. Epub 2013 Oct 30.

19.

The effects of selection and genetic drift on the genomic distribution of sexually antagonistic alleles.

Mullon C, Pomiankowski A, Reuter M.

Evolution. 2012 Dec;66(12):3743-53. doi: 10.1111/j.1558-5646.2012.01728.x. Epub 2012 Aug 22.

PMID:
23206133
20.

Molecular evolution of Drosophila Sex-lethal and related sex determining genes.

Mullon C, Pomiankowski A, Reuter M.

BMC Evol Biol. 2012 Jan 14;12:5. doi: 10.1186/1471-2148-12-5.

21.

Anemia management in patients receiving chronic hemodialysis.

Thakuria M, Ofsthun NJ, Mullon C, Diaz-Buxo JA.

Semin Dial. 2011 Sep-Oct;24(5):597-602. doi: 10.1111/j.1525-139X.2011.00975.x.

PMID:
21999745
22.

The HepatAssist bioartificial liver support system: clinical study and pig hepatocyte process.

Mullon C, Pitkin Z.

Expert Opin Investig Drugs. 1999 Mar;8(3):229-35.

PMID:
15992074
23.

A mathematical derivation of size spectra in fish populations.

Arino O, Shin YJ, Mullon C.

C R Biol. 2004 Mar;327(3):245-54. Review.

PMID:
15127895
24.

Islet allograft survival in nonhuman primates immunosuppressed with basiliximab, RAD, and FTY720.

Wijkstrom M, Kenyon NS, Kirchhof N, Kenyon NM, Mullon C, Lake P, Cottens S, Ricordi C, Hering BJ.

Transplantation. 2004 Mar 27;77(6):827-35.

PMID:
15077021
25.

The isolation and function of porcine islets from market weight pigs.

O'Neil JJ, Stegemann JP, Nicholson DT, Gagnon KA, Solomon BA, Mullon CJ.

Cell Transplant. 2001;10(3):235-46.

PMID:
11437069
26.

Comparison of analytical methods for quantitation of isolated porcine hepatocyte yields.

Stegemann JP, Raina S, Nicholson DT, Jimenez P, Shah L, Cain S, Chandler B, Pitkin Z, Mullon C, Custer L.

Tissue Eng. 2000 Jun;6(3):253-64.

PMID:
10941220
28.

Overview of extracorporeal liver support systems and clinical results.

McLaughlin BE, Tosone CM, Custer LM, Mullon C.

Ann N Y Acad Sci. 1999 Jun 18;875:310-25. Review.

PMID:
10415578
29.

Bioartificial organs may help reduce risk of zoonosis in xenotransplantation.

Mullon C.

Artif Organs. 1999 Apr;23(4):366-7. No abstract available.

PMID:
10226702
31.

Improved assessment of isolated islet tissue volume using digital image analysis.

Stegemann JP, O'Neil JJ, Nicholson DT, Mullon CJ.

Cell Transplant. 1998 Sep-Oct;7(5):469-78.

PMID:
9786067
32.

Transplantation of hepatocytes for prevention of intracranial hypertension in pigs with ischemic liver failure.

Arkadopoulos N, Chen SC, Khalili TM, Detry O, Hewitt WR, Lilja H, Kamachi H, Petrovic L, Mullon CJ, Demetriou AA, Rozga J.

Cell Transplant. 1998 Jul-Aug;7(4):357-63.

PMID:
9710304
33.

Treatment of severe liver failure with a bioartificial liver.

Chen SC, Mullon C, Kahaku E, Watanabe F, Hewitt W, Eguchi S, Middleton Y, Arkadopoulos N, Rozga J, Solomon B, Demetriou AA.

Ann N Y Acad Sci. 1997 Dec 31;831:350-60.

PMID:
9616727
34.

Functional recovery of porcine hepatocytes after hypothermic or cryogenic preservation for liver support systems.

Naik S, Santangini HA, Trenkler DM, Mullon CJ, Solomon BA, Pan J, Jauregui HO.

Cell Transplant. 1997 Sep-Oct;6(5):447-54.

PMID:
9331495
35.

Evaluation of anti-AIDS drugs in conventional mice implanted with a permeable membrane device containing human T cells infected with HIV.

Quenelle DC, Keith KA, Dunleavy KE, Taylor BA, Bowdon BJ, Brazier AD, Mullon CJ, HarrisRE, Allen LB.

Antiviral Res. 1997 Jul;35(2):123-9.

PMID:
9217249
36.

Automated counting and sizing of isolated porcine islets using digital image analysis.

Stegemann JP, O'Neil JJ, Nicholson DT, Mullon CJ, Solomon BA.

Transplant Proc. 1997 Jun;29(4):2272-3. No abstract available.

PMID:
9193623
37.

Immunoprotection provided by the bioartificial pancreas in a xenogeneic host.

O'Neil JJ, Stegemann JP, Nicholson DT, Mullon CJ, Maki T, Monaco AP, Solomon BA.

Transplant Proc. 1997 Jun;29(4):2116-7. No abstract available.

PMID:
9193550
38.

Clinical experience with a bioartificial liver in the treatment of severe liver failure. A phase I clinical trial.

Watanabe FD, Mullon CJ, Hewitt WR, Arkadopoulos N, Kahaku E, Eguchi S, Khalili T, Arnaout W, Shackleton CR, Rozga J, Solomon B, Demetriou AA.

Ann Surg. 1997 May;225(5):484-91; discussion 491-4.

39.

Porcine islets for xenotransplantation.

Maki T, O'Neil JJ, Porter J, Mullon CJ, Solomon BA, Monaco AP.

Transplantation. 1996 Jul 15;62(1):136-8.

PMID:
8693532
40.

Long-term function of porcine islets in xenogeneic hosts.

Maki T, O'Neill JJ, Porter J, Mullon CJ, Solomon BA, Monaco AP.

Transplant Proc. 1996 Apr;28(2):807. No abstract available.

PMID:
8623409
41.

Treatment of diabetes by xenogeneic islets without immunosuppression. Use of a vascularized bioartificial pancreas.

Maki T, Otsu I, O'Neil JJ, Dunleavy K, Mullon CJ, Solomon BA, Monaco AP.

Diabetes. 1996 Mar;45(3):342-7.

PMID:
8593940
42.

Early treatment of diabetes with porcine islets in a bioartificial pancreas.

Maki T, Monaco AP, Mullon CJ, Solomon BA.

Tissue Eng. 1996 Winter;2(4):299-306. doi: 10.1089/ten.1996.2.299.

PMID:
19877961
43.

Novel delivery of pancreatic islet cells to treat insulin-dependent diabetes mellitus.

Maki T, Mullon CJ, Solomon BA, Monaco AP.

Clin Pharmacokinet. 1995 Jun;28(6):471-82. Review.

PMID:
7656505
44.

In vivo evaluation of a hollow fiber liver assist device.

Jauregui HO, Mullon CJ, Trenkler D, Naik S, Santangini H, Press P, Muller TE, Solomon BA.

Hepatology. 1995 Feb;21(2):460-9.

PMID:
7843721
45.

Primary cultures of rat hepatocytes in hollow fiber chambers.

Jauregui HO, Naik S, Santangini H, Pan J, Trenkler D, Mullon C.

In Vitro Cell Dev Biol Anim. 1994 Jan;30A(1):23-9.

PMID:
8193770
46.

Enzymatic modification of plasma low density lipoproteins in rabbits: a potential treatment for hypercholesterolemia.

Labeque R, Mullon CJ, Ferreira JP, Lees RS, Langer R.

Proc Natl Acad Sci U S A. 1993 Apr 15;90(8):3476-80.

47.

Extracorporeal enzymatic removal of low density lipoproteins in rabbits: efficacy and safety.

Shefer SD, Ferreira J, Mullon CJ, Langer R.

Int J Artif Organs. 1993 Apr;16(4):218-28.

PMID:
8325700
48.

Oral treatment for jaundice using immobilized bilirubin oxidase.

Soltys PJ, Mullon C, Langer R.

Artif Organs. 1992 Aug;16(4):331-5.

PMID:
10078270
49.

A mathematical analysis of the U-shaped hybrid artificial pancreas--a novel insulin release rate equation.

Mullon CJ, Norton CA.

Biomater Artif Cells Artif Organs. 1990;18(1):43-57. Review. Erratum in: Biomater Artif Cells Artif Organs 1990;18(3):451.

PMID:
2185856
50.

Simulation of bilirubin detoxification in the newborn using an extracorporeal bilirubin oxidase reactor.

Mullon CJ, Tosone CM, Langer R.

Pediatr Res. 1989 Nov;26(5):452-7. Erratum in: Pediatr Res 1990 Feb;27(2):117.

PMID:
2812897

Supplemental Content

Loading ...
Support Center